Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Understanding neurocognitive outcomes in Pediatric Brain Tumour Survivors in context: Examining medical and sociodemographic risk factors
  • +8
  • Yustine Alejandra Carruyo Soto,
  • Laurianne Buron,
  • Clémentine Lopez,
  • Kristopher Lamore,
  • Cécile Flahault,
  • Estelle Favré,
  • Lucille Karsenti,
  • Serge Sultan,
  • Christelle Dufour,
  • Émélie Rondeau,
  • Leandra Desjardins
Yustine Alejandra Carruyo Soto
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Laurianne Buron
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Clémentine Lopez
Gustave Roussy
Author Profile
Kristopher Lamore
Gustave Roussy
Author Profile
Cécile Flahault
Gustave Roussy
Author Profile
Estelle Favré
Gustave Roussy
Author Profile
Lucille Karsenti
Gustave Roussy
Author Profile
Serge Sultan
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Christelle Dufour
Gustave Roussy
Author Profile
Émélie Rondeau
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Leandra Desjardins
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine

Corresponding Author:[email protected]

Author Profile

Abstract

Background. Pediatric Brain Tumour Survivors (PBTS) are at risk of neurocognitive impairments. This study assesses both objective and parent-reported cognitive functioning in PBTS and examines how various factors (medical and socio-demographic) may contribute to cognitive outcomes. PBTS ( n = 100) were on average 5.77 years old at diagnosis, 12.36 years from diagnosis, and 47% female. Method. Participant IQ was measured using the full-scale IQ of the WISC-IV and WISC-V, and executive function using the BRIEF2 Global Executive Composite. Examined contributors included: age, sex, tumour location, time since diagnosis, radiation type, chemotherapy dose (high versus low), parent’s education level and mother’s partnered status. Results. Higher IQ was correlated with higher executive function skills. Differential patterns were observed with socio-demographic variables influencing working memory, while radiation influenced processing speed. Higher education level in both mothers and fathers and maternal partnered status were associated with higher child working memory. Proton radiation was associated with higher processing speed scores. However, only time since diagnosis contributed to total IQ and working memory in multiple linear regression analyses. Conclusion. The findings shed light on the sparsely examined domain of the impact of socio-demographic variables on neurocognitive outcomes in PBTS. Time since diagnosis remains a significant predictor of cognitive performance, accentuating the need for early identification and intervention in PBTS.